Compounds > ly 293558
Page last updated: 2024-09-03

ly 293558 and Nerve Degeneration

ly 293558 has been researched along with Nerve Degeneration in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; Figueiredo, TH; Olsen, CH; Prager, EM1
Almeida-Suhett, CP; Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Miller, SL; Prager, EM1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Green, CE; Qashu, F; Swezey, R; Yang, C1
Gill, R; Lodge, D1

Other Studies

4 other study(ies) available for ly 293558 and Nerve Degeneration

ArticleYear
Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.
    Neurotoxicity research, 2017, Volume: 32, Issue:4

    Topics: Amygdala; Animals; Cholinesterase Inhibitors; Hippocampus; Isoquinolines; Male; Nerve Degeneration; Neuropathology; Rats, Sprague-Dawley; Seizures; Status Epilepticus; Tetrazoles

2017
A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.
    Toxicology and applied pharmacology, 2015, Apr-15, Volume: 284, Issue:2

    Topics: Acetylcholinesterase; Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Isoquinolines; Male; Nerve Degeneration; Oximes; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Seizures; Soman; Status Epilepticus; Tetrazoles

2015
Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1

    Topics: Animals; Anticonvulsants; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Electroencephalography; Fluoresceins; Fluorescent Dyes; Injections, Intramuscular; Isoquinolines; Male; Muscarinic Antagonists; Nerve Degeneration; Oximes; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Seizures; Soman; Tetrazoles; Tissue Fixation

2013
The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia.
    Neuropharmacology, 1994, Volume: 33, Issue:12

    Topics: Analysis of Variance; Animals; Ischemic Attack, Transient; Isoquinolines; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tetrazoles

1994